CLNPHARMA/ PLCLNPH00015 /
| 2024-05-02 5:00:00 PM | Chg. +0.36 | Volume | Bid9:10:00 PM | Ask9:10:00 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 15.52PLN | +2.37% | 49,759 Turnover: 766,493.08 |
-Bid Size: - | -Ask Size: - | 792.06 mill.PLN | 0.58% | - |
Fundamentals
| FY 2022 | Growth (1Y) | |
|---|---|---|
| Per Share | ||
| Earnings per Share: | -0.77 PLN | 208.00% |
| EPS Diluted: | - PLN | 208.00% |
| Revenues per Share: | 3.81 PLN | -2.34% |
| Book Value per Share: | 9.40 PLN | -13.48% |
| Cash Flow per Share: | -0.09 PLN | - |
| Dividend per Share: | 0.09 PLN | -68.97% |
| Total | in th. | |
| Revenues: | 194,592.00 PLN | -2.27% |
| Net Income: | -39,277.00 PLN | 238.39% |
| Operating Cash Flow: | -4,701.00 PLN | - |
| Cash and Cash Equivalents: | 82,902.00 PLN | - |
Valuation Ratios
| Current | Latest FY* | |
|---|---|---|
| P/E Ratio: | - | - |
| P/S Ratio: | 4.07 | 3.68 |
| P/BV ratio: | 1.65 | 1.49 |
| P/CF Ratio: | -168.49 | -152.20 |
| PEG: | -0.10 | - |
| Earnings Yield: | -4.96% | -5.49% |
| Dividend Yield: | 0.58% | 0.64% |
| Market Capitalization | ||
| Market Capitalization: | 792.06 mill. PLN | 715.51 mill. PLN |
| Free Float Market Cap.: | - PLN | - PLN |
| Market Cap. / Employee: | 1.51 mill. PLN | 1.37 mill. PLN |
| Shares Outstanding: | 51.04 mill. | |
Profitability
| Gross Profit Margin: | -18.90% |
| EBIT Margin: | -19.19% |
| Net Profit Margin: | -20.18% |
| Return on Equity: | -8.19% |
| Return on Assets: | -6.11% |
Financial Strength
| Liquidity I / Cash Ratio: | 71.20% |
| Liquidity II / Quick Ratio: | 94.48% |
| Liquidity III / Current Ratio: | 204.04% |
| Debt / Equity Ratio: | 34.01% |
| Dynam. Debt / Equity Ratio: | -3,469.84% |
Efficiency
| Employees: | 523 |
| Personal Expenses / Employee: | - PLN |
| Revenues / Employee: | 372,068.83 PLN |
| Net Income / Employee: | -75,099.43 PLN |
| Total Assets / Employee: | 1,228,992.35 PLN |
| * Fiscal Year End: | 2022-12-31 |
| Accounting Standard: | IFRS |
| Currency: | PLN |
